VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $370 | -18.5% | 13,738 | -8.9% | 0.06% | -14.7% |
Q2 2023 | $454 | -7.2% | 15,083 | -0.1% | 0.07% | -11.7% |
Q1 2023 | $489 | -10.9% | 15,101 | -21.2% | 0.08% | -15.4% |
Q4 2022 | $549 | -99.9% | 19,159 | +0.2% | 0.09% | +5.8% |
Q3 2022 | $461,000 | -11.7% | 19,114 | +0.2% | 0.09% | -8.5% |
Q2 2022 | $522,000 | -28.4% | 19,075 | +0.4% | 0.09% | -27.7% |
Q1 2022 | $729,000 | +115.7% | 19,005 | +79.8% | 0.13% | +103.1% |
Q4 2021 | $338,000 | +8.0% | 10,568 | -0.4% | 0.06% | -3.0% |
Q3 2021 | $313,000 | -15.2% | 10,610 | -2.4% | 0.07% | -17.5% |
Q2 2021 | $369,000 | -84.3% | 10,870 | -85.0% | 0.08% | -85.6% |
Q1 2021 | $2,348,000 | +546.8% | 72,234 | +616.8% | 0.56% | +523.6% |
Q4 2020 | $363,000 | -10.6% | 10,077 | -2.8% | 0.09% | -17.6% |
Q3 2020 | $406,000 | -22.5% | 10,370 | -27.4% | 0.11% | -28.5% |
Q2 2020 | $524,000 | +57.8% | 14,278 | -0.8% | 0.15% | +45.2% |
Q1 2020 | $332,000 | – | 14,398 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |